In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2

In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2

Show other versions (1)

Bibliographic Details
Main Authors:	Mohibullah Shah, Ramsha Yamin, Iqra Ahmad, Gang Wu, Zainab Jahangir, Amen Shamim, Haq Nawaz, Umar Nishan, Riaz Ullah, Essam A. Ali, Sheheryar, Ke Chen
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10766191/?tool=EBI

Similar Items

In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2.
by: Mohibullah Shah, et al.
Published: (2024-01-01)

Identifying plant-derived antiviral alkaloids as dual inhibitors of SARS-CoV-2 main protease and spike glycoprotein through computational screening
by: Ramsha Yamin, et al.
Published: (2024-07-01)

Identification of Novel Quinolone and Quinazoline Alkaloids as Phosphodiesterase 10A Inhibitors for Parkinson’s Disease through a Computational Approach
by: Iqra Ahmad, et al.
Published: (2024-03-01)

Exploring cotton plant compounds for novel treatments against brain-eating Naegleria fowleri: An In-silico approach.
by: Aqal Zaman, et al.
Published: (2025-01-01)

Antidiabetic activities of alkaloids isolated from medicinal plants
by: Ijaz Muhammad, et al.
Published: (2021-11-01)

Technical Data of In Silico Analysis of the Interaction of Dietary Flavonoid Compounds against Spike-Glycoprotein and Proteases of SARS-CoV-2
by: Nurbella Sofiana Altu, et al.
Published: (2022)

Technical Data of In Silico Analysis of the Interaction of Dietary Flavonoid Compounds against Spike-Glycoprotein and Proteases of SARS-CoV-2
by: Nurbella Sofiana Altu, et al.
Published: (2022-10-01)

Exploring the genomic potential of Kytococcus schroeteri for antibacterial metabolites against multi-drug resistant Mycobacterium tuberculosis
by: Fatiha Khan, et al.
Published: (2025-01-01)

Interaction of Epigallocatechin Gallate and Quercetin with Spike Glycoprotein (S-Glycoprotein) of SARS-CoV-2: In Silico Study
by: Mehran Alavi, et al.
Published: (2022-11-01)

In silico study of alkaloids with quercetin nucleus for inhibition of SARS-CoV-2 protease and receptor cell protease
by: Ali Mohebbi, et al.
Published: (2024-01-01)

In silico study of alkaloids with quercetin nucleus for inhibition of SARS-CoV-2 protease and receptor cell protease.
by: Ali Mohebbi, et al.
Published: (2024-01-01)

In silico analysis of SARS-CoV-2 spike glycoprotein and insights into antibody binding
by: Victor Padilla-Sanchez
Published: (2020-06-01)

Computational View toward the Inhibition of SARS-CoV-2 Spike Glycoprotein and the 3CL Protease
by: Zhen Qiao, et al.
Published: (2020-05-01)

In silico exploration of Lycoris alkaloids as potential inhibitors of SARS-CoV-2 main protease (Mpro)
by: Fredrick Mutie Musila, et al.
Published: (2022-09-01)

Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study
by: Gema Lizbeth Ramírez-Salinas, et al.
Published: (2020-11-01)

Phytobioinformatics screening of ayurvedic plants for potential α-glucosidase inhibitors in diabetes management
by: Hira Khalid, et al.
Published: (2024-12-01)

Structural informatics approach for designing an epitope-based vaccine against the brain-eating Naegleria fowleri
by: Asifa Sarfraz, et al.
Published: (2023-10-01)

Corrigendum: Structural informatics approach for designing an epitope-based vaccine against the brain-eating Naegleria fowleri
by: Asifa Sarfraz, et al.
Published: (2023-12-01)

Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein
by: Evgenii V. Matveev, et al.
Published: (2024-02-01)

Structures and dynamics of the novel S1/S2 protease cleavage site loop of the SARS-CoV-2 spike glycoprotein
by: Thomas Lemmin, et al.
Published: (2020-01-01)

Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.
by: Yiu-Wing Kam, et al.
Published: (2009-11-01)

Computer-assisted discovery of natural inhibitors for platelet-derived growth factor alpha as novel therapeutics for thyroid cancer
by: Hira Khalid, et al.
Published: (2025-01-01)

Prediction of B-cell and T-cell epitopes in the spike glycoprotein of SARS-CoV-2 in Bangladesh: An in-silico approach
by: Mehedi Hasan, et al.

Genome-level therapeutic targets identification and chimeric Vaccine designing against the Blastomyces dermatitidis
by: Sawvara Mursaleen, et al.
Published: (2024-08-01)

In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis
by: Azza Hanif Harisna, et al.
Published: (2021-07-01)

In Silico Studies on The Potential of Green Tea Catechin Compounds (Camellia sinensis) as Antiviral of SARS CoV-2 Againts Spike Glycoprotein (6LZG) and Main Protease (5R7Y)
by: Futna Naufa, et al.
Published: (2022-03-01)

Computer-aided identification of Mycobacterium tuberculosis resuscitation-promoting factor B (RpfB) inhibitors from Gymnema sylvestre natural products
by: Mohibullah Shah, et al.
Published: (2023-11-01)

In silico-based Discovery of New Potential Drugs Targeting Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein
by: Hayam Abdelkader, et al.
Published: (2021-11-01)

Corrigendum: Synthesis and Cytotoxic Activity of Novel Indole Derivatives and Their in silico Screening on Spike Glycoprotein of SARS-CoV-2
by: Perumal Gobinath, et al.
Published: (2021-08-01)

Integrative physiological, biochemical, and proteomic analysis of the leaves of two cotton genotypes under heat stress.
by: Asia Perveen, et al.
Published: (2025-01-01)

Orthobunyavirus ultrastructure and the curious tripodal glycoprotein spike.
by: Bowden, T, et al.
Published: (2013)

Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
by: Lin Wang, et al.
Published: (2020-11-01)

Incorporation of Spike and Membrane Glycoproteins into Coronavirus Virions
by: Makoto Ujike, et al.
Published: (2015-04-01)

In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2
by: Kunal Bhattacharya, et al.
Published: (2022-03-01)

Beneficial Effects of Natural Alkaloids from Berberis glaucocarpa as Antidiabetic Agents: An In Vitro, In Silico, and In Vivo Approach
by: Muhammad Alamzeb, et al.
Published: (2024-02-01)

In Silico Activity Identification of Cyclo Peptide Alkaloids from Zizyphus Spina-Christi Species Against Sars-Cov-2 Main Protease
by: Taufik Muhammad Fakih, et al.
Published: (2021-06-01)

Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors
by: Rishikesh Lotke, et al.
Published: (2024-02-01)

Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study
by: Trina Ekawati Tallei, et al.
Published: (2020-01-01)

Molecular docking analysis of anti-severe acute respiratory syndrome-Coronavirus 2 ligands against spike glycoprotein and the 3-chymotrypsin-like protease
by: Ali Hassan Daghir Janabi
Published: (2021-01-01)

Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming
by: Elisa Barile, et al.
Published: (2020-05-01)